Suppression of Choroidal Neovascularization by Intravitreal Injection of Liposomal SU5416

Archives of Ophthalmology
doi 10.1001/archophthalmol.2011.12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Suppression of Laser-Induced Choroidal Neovascularization by a CCR3 Antagonist

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Angioid Streaks

Archives of Ophthalmology
2007English

Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization Associated With Pattern Dystrophy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Angioid Streaks in a Non-Responder to Intravitreal Ranibizumab

International Medical Case Reports Journal
Medicine
2018English

Macular Hole Retinal Detachment After Intravitreal Conbercept Injection for the Treatment of Choroidal Neovascularization Secondary to Degenerative Myopia: A Case Report

BMC Ophthalmology
MedicineOphthalmology
2019English

Resolution of Vitreomacular Traction Following Intravitreal Ranibizumab in Cases of Ocular Toxoplasmosis With Choroidal Neovascularization

Therapeutics and Clinical Risk Management
2013English

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent Against (Pro)renin Receptor

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Prognostic Factors for Visual Outcomes 2-Years After Intravitreal Bevacizumab for Myopic Choroidal Neovascularization

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2011English

Three Consecutive Monthly Intravitreal Ranibizumab for Choroidal Neovascularization in Central Serous Choriorethinopathy: A Case Report

Open Journal of Ophthalmology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy